Eosinophil CD48 interactions with Candida albicans Als6 is protective in vitro and in mouse systemic candidiasis
Eosinophils are innate immune cells with central roles in allergy, parasitic diseases and multiple inflammatory conditions. Moreover, their role in host-pathogen interactions has been well characterized. However, the role of eosinophils during fungal infection is poorly defined. In this study, we delineate the importance of eosinophils during C. albicans systemic infections. C. albicans is promptly phagocytosed by human eosinophils, but growing hyphae escape this mechanism by releasing the fungal toxin candidalysin, which causes eosinophil membrane damage and cell death. Concomitantly, eosinophil mediators, notably major basic protein 1 (MBP-1), released during cytolysis, inhibits C. albicans growth and viability. Moreover, systemic candidiasis in genetic (Δdbl/GATA) or anti-IL-5-mediated depletion of eosinophils results in increased fungal burden and decreased survival. We here identified CD48 as a major receptor of eosinophils and possibly of other immune cells involved in the recognition of C. albicans via agglutinin-like sequence 6 (Als6). CD48 is important for protection in a model of systemic candidiasis as shown in CD48<sup>-/-</sup> mice and it binds clinical isolates of C. albicans. In conclusion, we have defined a protective role for eosinophils in vitro and in mouse C. albicans infections through CD48/Als6 host-pathogen interaction axis.
Authors
- Ilan Zaffran
- Bernhard Hube (ORCID: https://orcid.org/0000-0002-6028-0425)
- Julian R. Naglik (ORCID: https://orcid.org/0000-0002-8072-7917)
- Joana Vitte (ORCID: https://orcid.org/0000-0002-3344-9408)
- Ronen Ben‐Ami (ORCID: https://orcid.org/0000-0003-0628-0798)
- Ofer Mandelboim (ORCID: https://orcid.org/0000-0002-9354-1855)
- David Shasha
- Francesca Levi‐Schaffer (ORCID: https://orcid.org/0000-0003-0620-2810)
- Yoav Charpak‐Amikam (ORCID: https://orcid.org/0000-0001-7625-0741)
- Nir Osherov (ORCID: https://orcid.org/0000-0002-0433-0096)
- Pratibha Gaur (ORCID: https://orcid.org/0000-0002-3155-5944)
- Hadas Pahima
- Prince Ofori (ORCID: https://orcid.org/0000-0002-6885-1907)
Institutions
- Inserm (FR)
- Tel Aviv University (IL)
- King's College London (GB)
- Hebrew University of Jerusalem (IL)
- Université de Montpellier (FR)
- Tel Aviv Sourasky Medical Center (IL)
- Centre Hospitalier Universitaire de Reims (FR)
- Concern Foundation (US)
- Institute for Neurosciences of Montpellier (FR)
- Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) (DE)
- Friedrich Schiller University Jena (DE)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1038/s41467-025-64276-3
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Hebrew University of Jerusalem
- Tel Aviv University
- Iran Science Elites Federation